The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DMTomohiro Koga, Atsushi Kawakami, Shin‐ya Kawashiri et al.|Lara D. Veeken|2012Cited by 321
Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositisYoshiro Horai, Atsushi Kawakami, Tomohiro Koga et al.|Modern Rheumatology|2014Cited by 85